Treatment outcomes of resected esophageal cancer

被引:237
作者
Hofstetter, W
Swisher, SG
Correa, AM
Hess, K
Putnam, JB
Ajani, JA
Dolormente, M
Francisco, R
Komaki, RR
Lara, A
Martin, F
Rice, DC
Sarabia, AJ
Smythe, WR
Vaporciyan, AA
Walsh, GL
Roth, JA
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Esophageal Canc Program, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Gastrointestinal Oncol, Houston, TX 77030 USA
[4] Univ Texas, MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
关键词
D O I
10.1097/00000658-200209000-00014
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective To assess the evolution of treatment and outcome for resected esophageal cancer at a single institution. Summary Background Data Strategies for optimizing the treatment of resected esophageal cancer continue to evolve over time. The outcomes of these evolving treatments in the context of improved diagnostic staging and changing epidemiology have not been carefully analyzed in a single institution. Methods One thousand ninety-seven consecutive patients with primary esophageal cancer underwent surgery during the period 1970 to 2001. Nine hundred ninety-four patients underwent curative esophagectomy and were analyzed for changing demographics. Eight hundred seventy-nine patients who did not have systemic metastases and survived the perioperative period were assessed by multivariate analysis for factors associated with long-term survival. Results During the study period the overall median survival increased from 17 to 34 months, and combined hospital and 30-day mortality decreased from 12% to 6%. The R0 resection rate increased from 78 to 94%, and adenocarcinoma replaced squamous cell carcinoma as the predominant histology (83% vs. 17%). No change in survival with time was noted for patients treated with surgery alone having the same postoperative pathologic stage (pTNM). An increased proportion of patients had preoperative chemoradiation in the last 4 years of the study (59% vs. 2%). Preoperative chemoradiation was associated with a longer survival and increased likelihood of achieving a complete resection. Multivariate analysis showed that long-term survival was associated with a complete resection and the preoperative staging strategy used, while the use of preoperative chemoradiation was the most significant factor associated with ability to achieve an RO esophageal resection. Conclusions This study shows favorable trends in the survival of patients with resected esophageal cancer over time. The increased use of preoperative chemoradiation, better preoperative staging, and other time-dependent factors may have contributed to the observed increase in survival.
引用
收藏
页码:376 / 385
页数:10
相关论文
共 33 条
[1]  
Ajani JA, 2001, CANCER-AM CANCER SOC, V92, P279, DOI 10.1002/1097-0142(20010715)92:2<279::AID-CNCR1320>3.0.CO
[2]  
2-2
[3]   Should en bloc esophagectomy be the standard of care for esophageal carcinoma? [J].
Altorki, N ;
Skinner, D .
ANNALS OF SURGERY, 2001, 234 (05) :581-587
[4]   LOW-DOSE PREOPERATIVE RADIOTHERAPY FOR CARCINOMA OF THE ESOPHAGUS - RESULTS OF A RANDOMIZED CLINICAL-TRIAL [J].
ARNOTT, SJ ;
DUNCAN, W ;
KERR, GR ;
WALBAUM, PR ;
CAMERON, E ;
JACK, WJL ;
MACKILLOP, WJ .
RADIOTHERAPY AND ONCOLOGY, 1992, 24 (02) :108-113
[5]   Impact of hospital volume on operative mortality for major cancer surgery [J].
Begg, CB ;
Cramer, LD ;
Hoskins, WJ ;
Brennan, MF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (20) :1747-1751
[6]   RISING INCIDENCE OF ADENOCARCINOMA OF THE ESOPHAGUS AND GASTRIC CARDIA [J].
BLOT, WJ ;
DEVESA, SS ;
KNELLER, RW ;
FRAUMENI, JF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (10) :1287-1289
[7]   Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus [J].
Bosset, JF ;
Gignoux, M ;
Triboulet, JP ;
Tiret, E ;
Mantion, G ;
Elias, D ;
Lozach, P ;
Ollier, JC ;
Pavy, JJ ;
Mercier, M ;
Sahmoud, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (03) :161-167
[8]  
CLARK P, 2001, P AN M AM SOC CLIN, V20, pA126
[9]   Columnar mucosa and intestinal metaplasia of the esophagus - Fifty years of controversy [J].
DeMeester, SR ;
DeMeester, TR .
ANNALS OF SURGERY, 2000, 231 (03) :303-321
[10]   Esophagogastrectomy for carcinoma of the esophagus and cardia: A comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria [J].
Ellis, FH ;
Heatley, GJ ;
Krasna, MJ ;
Williamson, WA ;
Balogh, K .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 113 (05) :836-846